Only 39 patients ( 33.6 % ) insisted on taking lipid-lowering drug orally; 只有39例(33.6%)患者坚持服用调脂药;
The clinical efficacy of lipid-lowering drug in hyperlipidemia with fatty liver : one clinical observation 调脂药物应用于高脂血症并脂肪肝治疗的临床观察
The use of β - blocker, ACEI, antiplatelet agents and lipid-lowering drug increased, and the patients receiving calcium antagonists decreased in recent 10 years. 抗血小板和抗凝药物、β受体阻滞剂、血管紧张素转换酶抑制剂及降脂药(LLD)物的使用率呈逐年增多的趋势,钙离子拮抗剂使用率有逐年下降的趋势。
For instance, owing to its side effects, lipid-lowering drug Baycol has been forbidden to be used. 降血脂药拜斯亭因有副作用发生已被停用。
The drug was first developed by Merck and Schering-Plough together. It occupied certain share of the lipid-lowering drug market, with a great prospects for development in good economic and social values. 该药最先由Merck公司和Schering-Plough共同研制,目前该药在市场上占有一定的份额,且发展前景巨大,具有良好的经济价值和社会价值。